1. Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer
   Yu Bai et al, 2019, Current Topics in Medicinal Chemistry CrossRef
2. Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor
   Sanil Bhatia et al, 2018, Journal of Medicinal Chemistry CrossRef
3. Brefeldin A Induces Apoptosis, Inhibits BCR-ABL Activation, and Triggers BCRABL Degradation in Chronic Myeloid Leukemia K562 Cells
   Jin-Man Zhang et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
4. MPT0B002, a novel microtubule inhibitor, downregulates T315I mutant Bcr-Abl and induces apoptosis of imatinib-resistant chronic myeloid leukemia cells
   Yi-Yen Yeh et al, 2017, Investigational New Drugs CrossRef
5. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations
   Nilsa Rivera-Del Valle et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
6. Oxidative stress response induced by chemotherapy in leukemia treatment (Review)
   Jin Zhang et al, 2018, Molecular and Clinical Oncology CrossRef
7. The FKH domain in FOXP3 mRNA frequently contains mutations in hepatocellular carcinoma that influence the subcellular localization and functions of FOXP3
   Jianwei Ren et al, 2020, Journal of Biological Chemistry CrossRef
8. Role of HDACs in normal and malignant hematopoiesis
   Pan Wang et al, 2020, Molecular Cancer CrossRef